Emergent BioSolutions

News and Video Search Results

News coverage

Lyophilization Services for Biopharmaceuticals Global Report 2024, Featuring Profiles of Strides Pharma Science, Baxter, Catalent Pharma Solutions, W. L. Gore & Associates and Emergent BioSolutions

GlobeNewswire 09 Apr 2024

Dublin, April 09, 2024 (GLOBE NEWSWIRE) -- The "Lyophilization Services for Biopharmaceuticals Global Market Report 2024" report..

XORTX Welcomes New Member to the Board of Directors
GlobeNewswire 08 Apr 2024
Antibody Therapeutics (Monoclonal, Polyclonal, Antibody Fragment, Bispecific) Market Research 2023: Advancements in Antibody Engineering and Growing Focus on Collaborations for Drug Discovery
GlobeNewswire 04 Apr 2024
Global Naloxone Market to Reach $2.1 Billion by 2030 with a CAGR of 10.8% - Market Growth Driven by Increasing Drug Dependency and Public Awareness
GlobeNewswire 03 Apr 2024
Global Convalescent Plasma Therapy Market to Grow at a CAGR of 11.8% from 2023 to 2024
GlobeNewswire 28 Mar 2024

0 shares 1 views

You might like

Emergent BioSolutions media coverage

Global Human Vaccines Market (2023-2028)

GlobeNewswire 27 Mar 2024

Dublin, March 27, 2024 (GLOBE NEWSWIRE) -- The "Global Human Vaccines Market (2023-2028) Competitive Analysis, Impact of Covid-19,..

Valneva Initiates Phase 1 Trial of Second-Generation Zika Vaccine Candidate
GlobeNewswire 26 Mar 2024
Emergent BioSolutions receives NAI status for Baltimore Bayview manufacturing facility
SeekingAlpha 25 Mar 2024
Emergent BioSolutions Receives NAI Status for Baltimore Bayview Manufacturing Facility
GlobeNewswire 25 Mar 2024
Valneva Reports Full Year 2023 Results and Provides Business Updates and Outlook
GlobeNewswire 20 Mar 2024

Advertisement

More coverage

Corona előrejelzés: Dr. Heiko Schöning megjósolta a Coronát 2019 szeptemberében!

Corona előrejelzés: Dr. Heiko Schöning megjósolta a Coronát 2019 szeptemberében!

Rumble 18 Mar 2024

Dr. Egy 2019. szeptember 11-i (2018-ban rögzített) interjúban Ken Jebsennel Heiko Schöning a 2020-ra tervezett..

Asia Pacific Preventive Vaccines Market to Hit Valuation of USD 63.11 Billion by 2032: Astute Analytica
GlobeNewswire 18 Mar 2024
Global Anthrax Vaccine Market Worth Over $22 Billion by 2034, Driven by Advanced Vaccine Developments and Rising Demand for Bioterrorism Defense
GlobeNewswire 11 Mar 2024
Benchmark upgrades Emergent Biosolutions to Buy
SeekingAlpha 07 Mar 2024
Emergent BioSolutions (EBS) Q4 2023 Earnings Call Transcript
Motley Fool 07 Mar 2024